212 related articles for article (PubMed ID: 3426916)
1. Evaluation of epidermal growth factor receptors in bladder tumours.
Berger MS; Greenfield C; Gullick WJ; Haley J; Downward J; Neal DE; Harris AL; Waterfield MD
Br J Cancer; 1987 Nov; 56(5):533-7. PubMed ID: 3426916
[TBL] [Abstract][Full Text] [Related]
2. Expression of mutant p53, c-erbB-2 and the epidermal growth factor receptor in transitional cell carcinoma of the human urinary bladder.
Wright C; Mellon K; Johnston P; Lane DP; Harris AL; Horne CH; Neal DE
Br J Cancer; 1991 Jun; 63(6):967-70. PubMed ID: 1712624
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of epidermal growth factor receptor DNA amplification and mRNA expression in bladder cancer.
Wood DP; Fair WR; Chaganti RS
J Urol; 1992 Jan; 147(1):274-7. PubMed ID: 1729545
[TBL] [Abstract][Full Text] [Related]
4. Epidermal-growth-factor receptors in human bladder cancer: comparison of invasive and superficial tumours.
Neal DE; Marsh C; Bennett MK; Abel PD; Hall RR; Sainsbury JR; Harris AL
Lancet; 1985 Feb; 1(8425):366-8. PubMed ID: 2857420
[TBL] [Abstract][Full Text] [Related]
5. Altered expression of epidermal growth factor receptors in human bladder and lung tumours.
Berger MS; Greenfield C; Waterfield MD
Princess Takamatsu Symp; 1986; 17():183-94. PubMed ID: 3332010
[TBL] [Abstract][Full Text] [Related]
6. Amplification and over-expression of c-erbB-2 in transitional cell carcinoma of the urinary bladder.
Coombs LM; Pigott DA; Sweeney E; Proctor AJ; Eydmann ME; Parkinson C; Knowles MA
Br J Cancer; 1991 Apr; 63(4):601-8. PubMed ID: 1673627
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of c-erbB-2 oncogene product and epidermal growth factor receptor expression in human urinary bladder carcinomas.
Asamoto M; Hasegawa R; Masuko T; Hashimoto Y; Ueda K; Ohtaguro K; Sasaki S; Washida H; Fukushima S
Acta Pathol Jpn; 1990 May; 40(5):322-6. PubMed ID: 2203226
[TBL] [Abstract][Full Text] [Related]
8. Molecular and immunohistochemical evaluation of epidermal growth factor receptor and c-erb-B-2 gene product in transitional cell carcinomas of the urinary bladder: a study in Greek patients.
Gorgoulis VG; Barbatis C; Poulias I; Karameris AM
Mod Pathol; 1995 Sep; 8(7):758-64. PubMed ID: 8539234
[TBL] [Abstract][Full Text] [Related]
9. Epidermal-growth-factor-receptor expression is associated with rapid tumor proliferation in bladder cancer.
Sauter G; Haley J; Chew K; Kerschmann R; Moore D; Carroll P; Moch H; Gudat F; Mihatsch MJ; Waldman F
Int J Cancer; 1994 May; 57(4):508-14. PubMed ID: 8181854
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptors in lung tumours.
Berger MS; Gullick WJ; Greenfield C; Evans S; Addis BJ; Waterfield MD
J Pathol; 1987 Aug; 152(4):297-307. PubMed ID: 3668732
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of EGF receptor and tumor cell proliferation in bladder cancer: therapeutic implications.
Popov Z; Gil-Diez-De-Medina S; Ravery V; Hoznek A; Bastuji-Garin S; Lefrere-Belda MA; Abbou CC; Chopin DK
Urol Oncol; 2004; 22(2):93-101. PubMed ID: 15082004
[TBL] [Abstract][Full Text] [Related]
12. Expression of c-erbB-2 gene product in urinary bladder cancer.
Moriyama M; Akiyama T; Yamamoto T; Kawamoto T; Kato T; Sato K; Watanuki T; Hikage T; Katsuta N; Mori S
J Urol; 1991 Feb; 145(2):423-7. PubMed ID: 1988741
[TBL] [Abstract][Full Text] [Related]
13. Immunocytochemical localization of c-erbB-2 protein in transitional cell carcinoma of the urinary bladder.
Coombs LM; Oliver S; Sweeney E; Knowles M
J Pathol; 1993 Jan; 169(1):35-42. PubMed ID: 8094432
[TBL] [Abstract][Full Text] [Related]
14. C-erbB-2 in bladder cancer: molecular biology, correlation with epidermal growth factor receptors and prognostic value.
Mellon JK; Lunec J; Wright C; Horne CH; Kelly P; Neal DE
J Urol; 1996 Jan; 155(1):321-6. PubMed ID: 7490879
[TBL] [Abstract][Full Text] [Related]
15. Receptors for hormones and growth factors and (onco)-gene amplification in human ovarian cancer.
Berns EM; Klijn JG; Henzen-Logmans SC; Rodenburg CJ; van der Burg ME; Foekens JA
Int J Cancer; 1992 Sep; 52(2):218-24. PubMed ID: 1325950
[TBL] [Abstract][Full Text] [Related]
16. Profile of epidermal growth factor receptor (EGFr) expression in human malignancies: effects of exposure to EGF and its biological influence on established human tumour cell lines.
Nouri AM; Thompson C; Cannell H; Symes M; Purkiss S; Amirghofran Z
Int J Mol Med; 2000 Oct; 6(4):495-500. PubMed ID: 10998445
[TBL] [Abstract][Full Text] [Related]
17. EGF stimulates anchorage-independent growth of a human bladder carcinoma cell line (KU1) with an amplified and over-expressed EGF receptor gene.
Ishikawa J; Maeda S; Sugiyama T; Nishimura R; Mizoguchi A; Kamidono S
Int J Cancer; 1989 Dec; 44(6):1000-4. PubMed ID: 2606569
[TBL] [Abstract][Full Text] [Related]
18. Ha-ras induction of the invasive phenotype results in up-regulation of epidermal growth factor receptors and altered responsiveness to epidermal growth factor in human papillary transitional cell carcinoma cells.
Theodorescu D; Cornil I; Sheehan C; Man MS; Kerbel RS
Cancer Res; 1991 Aug; 51(16):4486-91. PubMed ID: 1868471
[TBL] [Abstract][Full Text] [Related]
19. Expression of epidermal growth factor receptor in bladder cancer as related to established prognostic factors, oncoprotein (c-erbB-2, p53) expression and long-term prognosis.
Lipponen P; Eskelinen M
Br J Cancer; 1994 Jun; 69(6):1120-5. PubMed ID: 7911031
[TBL] [Abstract][Full Text] [Related]
20. Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin.
Libermann TA; Nusbaum HR; Razon N; Kris R; Lax I; Soreq H; Whittle N; Waterfield MD; Ullrich A; Schlessinger J
Nature; 1985 Jan 10-18; 313(5998):144-7. PubMed ID: 2981413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
